Medicare Enrolled
Dr. Craig Wilkenfeld, MD, FACC
Cardiovascular Disease · Englewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wilkenfeld from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilkenfeld?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wilkenfeld
Dr. Craig Wilkenfeld is a cardiovascular disease specialist in Englewood, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wilkenfeld performed 2,700 Medicare services across 1,550 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wilkenfeld received a total of $3,539 from 37 pharmaceutical and/or device companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wilkenfeld is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 49% volume in NJ
$3,539 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,700
Medicare services
Top 49% in NJ for cardiovascular disease
1,550
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~142 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
966 | $99 | $240 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
417 | $7 | $30 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
389 | $12 | $60 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
268 | $41 | $170 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
182 | $46 | $200 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
126 | $8 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
107 | $56 | $240 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $118 | $365 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
28 | $35 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $157 | $325 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
23 | $20 | $80 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
22 | $12 | $55 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
16 | $72 | $90 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $34 | $70 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
13 | $64 | $260 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $65 | $245 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
13 | $18 | $75 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
13 | $12 | $50 |
| New patient office visit, complex (60-74 min) | 13 | $168 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
1.9% medium
94.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,539
Total received (2018-2024)
Avg $506/year across 7 years
Top 44% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
273
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,539 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$480
2023
$529
2022
$586
2021
$246
2020
$210
2019
$592
2018
$895
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$132
CVRx, Inc.
$82
HEARTFLOW, INC.
$54
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$52
PFIZER INC.
$46
Merck Sharp & Dohme LLC
$19
Philips North America LLC
$18
iRhythm Technologies, Inc.
$17
Impulse Dynamics (USA) Inc.
$16
Alnylam Pharmaceuticals Inc.
$15
Novo Nordisk Inc
$15
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 55.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$701
Janssen Pharmaceuticals, Inc
$605
PFIZER INC.
$289
E.R. Squibb & Sons, L.L.C.
$248
CVRx, Inc.
$200
Amgen Inc.
$197
Merck Sharp & Dohme LLC
$165
Gilead Sciences, Inc.
$116
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
SANOFI-AVENTIS U.S. LLC
$88
Abbott Laboratories
$61
HEARTFLOW, INC.
$54
Edwards Lifesciences Corporation
$49
Novo Nordisk Inc
$47
Amarin Pharma Inc.
$39
Baxter Healthcare
$38
Boston Scientific Corporation
$35
AngioDynamics, Inc.
$35
Philips Electronics North America Corporation
$32
iRhythm Technologies, Inc.
$31
Alnylam Pharmaceuticals Inc.
$29
Chiesi USA, Inc.
$29
Merck Sharp & Dohme Corporation
$28
Esperion Therapeutics, Inc.
$26
Lundbeck LLC
$23
Philips North America LLC
$18
Impulse Dynamics (USA) Inc.
$16
Bardy Diagnostics, Inc.
$15
Medtronic Vascular, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Kiniksa Pharmaceuticals International, plc
$15
PORTOLA PHARMACEUTICALS, LLC
$14
AstraZeneca Pharmaceuticals LP
$14
PORTOLA PHARMACEUTICALS, INC.
$13
Regeneron Healthcare Solutions, Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (CK4) MCOT · AMVUTTRA · ANDEXXA · Adempas · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · Carnation Ambulatory Monitor · Circulatory Support · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FFRct · Hillrom - Cardiac Ambulatory Monitor · JARDIANCE · KENGREAL · LEQVIO · LifeVest · MITRACLIP · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · Optimizer · Ozempic · PRADAXA · PRALUENT · Ranexa · Repatha · Reveal LINQ · Rybelsus · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,865
Per 100K population
195.3
County median income
$123,715
Nearest hospital
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wilkenfeld is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wilkenfeld experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wilkenfeld performed 966 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wilkenfeld receive payments from pharmaceutical companies?
Yes. Dr. Wilkenfeld received a total of $3,539 from 37 companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilkenfeld's costs compare to other cardiologists in Englewood?
Dr. Wilkenfeld's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilkenfeld) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Englewood
Browse cardiologists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology